Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
NCT00082173
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
170
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
DRUG:
Moxifloxacin
Sponsor
Johns Hopkins University